Pentax Medical Company recalls Ultrasound Gastroscope Intended to provide optical visualization of, ultrasonic visualization of and therapeutic access…
- Recall date
- April 6, 2016
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-2077-2016
- FDA classification
- Class II
- Brand / firm
- Pentax Medical Company
- Sold / distributed
- Worldwide Distribution - US (Nation Wide) including Puerto Rico and Internationally to Denmark, Guam
Why it was recalled
Pentax has become aware that operational/cleaning accessories and therapeutic devices (e.g., clips, stents, balloons, etc.) can become lodged in an endoscope's instrument channel.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Ultrasound Gastroscope Intended to provide optical visualization of, ultrasonic visualization of and therapeutic access to, the Upper Gastrointestinal Track including but not restricted to organs, tissues and subsystems: Esophagus, Stomach, Duodenum, Small Bowel and underlying areas. The instrument is introduced orally when indications consistent with the requirement for procedure are observed in adult and pediatric
Get recall alerts
Free email alert whenever Pentax Medical Company has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Pentax Medical Company